Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Eton Pharmaceuticals (ETON) over the last 3 years, with Q1 2025 value amounting to $675000.0.

  • Eton Pharmaceuticals' Other Accumulated Expenses changed N/A to $675000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $675000.0, marking a year-over-year change of. This contributed to the annual value of $5.4 million for FY2023, which is N/A changed from last year.
  • Per Eton Pharmaceuticals' latest filing, its Other Accumulated Expenses stood at $675000.0 for Q1 2025.
  • Eton Pharmaceuticals' 5-year Other Accumulated Expenses high stood at $5.4 million for Q4 2023, and its period low was $675000.0 during Q1 2025.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $4.9 million (2024), whereas its average is $3.6 million.